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Cytosolic  HsP90  requires  multiple  cochaperones  in  folding  client  proteins.  However,  the 
function of gp96 (HsP90b1, grp94), an HsP90 paralogue in the endoplasmic reticulum (ER), 
is believed to be independent of cochaperones. Here, we demonstrate that gp96 chaperones 
multiple Toll-like receptors (TLRs), but not TLR3, in a manner that is dependent on another ER 
luminal protein, CnPY3. gp96 directly interacts with CnPY3, and the complex dissociates in 
the presence of adenosine triphosphate (ATP). Genetic disruption of gp96–CnPY3 interaction 
completely abolishes their TLR chaperone function. moreover, we demonstrate that TLR9 forms 
a multimolecular complex with gp96 and CnPY3, and the binding of TLR9 to either molecule 
requires the presence of the other. We suggest that CnPY3 interacts with the ATP-sensitive 
conformation of gp96 to promote substrate loading. our study has thus established CnPY3 as 
a TLR-specific cochaperone for gp96. 
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p96 is the endoplasmic reticulum (ER) resident member 
of the HSP90 family. Known also as grp94, HSPC4 (ref. 1) 
or HSP90b1 (ref. 2), gp96 has an intrinsic ATPase activ-
ity3–5 and it shares ~50% homology with the cytosolic HSP90 at the 
amino-acid level, consisting of the N-terminal adenosine triphos-
phate (ATP)-binding domain (N), followed by the charged middle 
domain (M) and the C-terminal homodimerization domain (C). It 
is constitutively expressed in virtually all cell types and its expres-
sion is upregulated by stress conditions that perturb ER functions6. 
HSP90 can chaperone up to 10% of the proteome7,8, and its function 
is assisted by a number of well-characterized cochaperones such as 
Hop, p23, Aha1 and CDC37 (ref. 9). These cochaperones modulate 
the ability of HSP90 to interact with its substrates and ATP, which 
are critical for the proper and necessary conformational changes of 
HSP90, including N-domain dimerization, in order to complete the 
cycle of substrate binding and release. Recently, gp96 has been found 
to be a master chaperone for multiple Toll-like receptors (TLRs) 
and integrins10–13. Deletion of gp96 in either macrophages or B cells 
resulted in inactivation of multiple TLRs at the post-translational 
level.  However,  it  remains  unclear  whether  gp96  chaperones  its   
client proteins alone or does so in concert with unidentified cochap-
erones. The prevailing idea has been that gp96 is a unique member 
of the HSP90 family in that it does not require a cochaperone for 
function14. Consistent with this notion is that gp96 does not share 
the common structural features with HSP90, such as the C-terminal 
methionine-glutamic acid-glutamic acid-valine-aspartic acid motif 
for binding to cochaperones. Yet, the structural study of the near 
full-length gp96 (NMC) clearly suggests that additional factors are 
necessary for N-domain dimerization of gp96, leading to optimal 
function5. The ‘extended-open’ form of the N and M domains of the 
gp96 dimer in the presence of ADP and adenylyl-imidodiphosphate 
(AMP-PNP) is incompatible with its chaperone function5.
TLRs are a family of pattern recognition receptors for patho-
gens that have critical roles in innate immunity against infection15. 
Thirteen TLRs exist in mammals and they localize either on the 
cell surface or in the endolysosome compartment. Surface TLRs, 
including TLR1, TLR2, TLR4, TLR5, TLR6 and TLR11, primarily 
recognize microbial non-nucleic acid structures. In contrast, intra-
cellular  TLRs  recognize  nucleic  acid-based  molecules:  TLR3  for 
double-stranded RNA (dsRNA), TLR7/8 for single-stranded RNA 
and TLR9 for DNA. All TLRs are type I transmembrane (tm) recep-
tors sharing characteristic structural features: an N-terminal ecto-
domain containing multiple leucine-rich repeats (LRRs) for ligand 
binding, a short helix embedded in the membrane and a C-terminal 
cytosolic tail containing the Toll-interleukin (IL)-1 receptor domain 
for recruiting signalling adaptors.
TLR9 resides in the ER in the steady state. It has to exit from 
the ER by binding to the membrane protein Unc93b (ref. 16), 
and is further matured by a proteolytic cleavage of the first 14 
N-terminal LRRs17,18 in the endolysosomal compartment where 
signals  originate19.  TLR9  binds  to  a  diverse  range  of  DNA 
sequences20, which induces a conformational change of the ecto-
domain  and  the  close  apposition  of  the  dimeric  cytoplasmic   
signalling tails21.
TLR3  is  a  pattern  recognition  receptor  for  dsRNA  produced 
commonly  as  the  viral  replication  intermediate22.  Activation  of 
TLR3 also occurs in the acidic endosomal location23. Unlike all 
other TLRs that can signal through MyD88, the signalling of TLR3 
depends exclusively on the cytosolic adaptor molecule TRIF24.
Murine canopy3 (CNPY3) (UniProt accession: Q9DAU1) is a 
ubiquitous ER luminal protein of ~35 kDa25. CNPY3 has a unique 
pattern  of  six  cysteine  residues26,  which  is  characteristic  of  the 
saposin-like proteins that form a shell-like dimer27. It also has a 
C-terminal basic region formed by a stretch of lysine-rich repeat. 
Although CNPY3 was initially thought to be important for TLR4 
expression and was also named PRAT4A (a protein interacting with 
TLR4)28, cnpy3 knockout (KO) mice lost the function of multiple 
TLRs post-translationally, except TLR3 (ref. 25).
In this study, we demonstrate that CNPY3 and gp96 depend 
on each other for post-translational maturation of multiple TLRs, 
except TLR3. CNPY3 and gp96 form a complex both in vitro and 
in vivo. The interaction between these two molecules is critical for 
TLR9 folding and transport to the endolysosomes. We conclude 
that CNPY3 is the elusive TLR-specific cochaperone of gp96. Fur-
thermore, we propose a model in which CNPY3 interacts with the 
ATP-sensitive conformation of the gp96 N domain to keep the over-
all structure of gp96 in the relaxed state in order to facilitate the 
‘loading’ of TLRs onto gp96 for completion of the folding cycle.
Results
gp96  and  CNPY3  are  dispensable  for  TLR3  function.  There 
are multiple dsRNA sensors in the cell, including the endosomal 
TLR3 and the cytosolic retinoic acid-inducible gene I, melanoma 
differentiation-associated gene 5 and protein kinase R29. We first 
performed a series of studies to resolve the role of gp96 in TLR3 
function. We found that gp96 KO peritoneal macrophages (pMφ) 
produced high levels of IL-6 and tumour-necrosis factor-α (Fig. 1a) 
after stimulation with a synthetic dsRNA analogue polyI:C30. The 
responsiveness of pMφ to polyI:C was mediated by TLR3 but not by 
TLR2 or TLR4, as it was abrogated in tlr3 − / −  pMφ, but preserved in 
tlr2 − / − tlr4 − / −  double KO cells. In addition, we found that gp96 KO 
B cells12 upregulated surface CD69 shortly after polyI:C stimulation, 
which was strictly dependent on TLR3 (ref. 22) (Fig. 1b). We also 
examined whether the function of enforced expression of TLR3 
required  gp96,  using  a  gp96  mutant  pre-B-cell  line  that  stably 
expresses a nuclear factor-κB-green fluorescent protein reporter11. 
Neither wild-type (WT) nor mutant (Mut) pre-B cells responded 
to polyI:C without enforced TLR3 expression (Fig. 1c). However, 
transfection  with  TLR3,  but  not  with  TLR9  expression  vector, 
rendered both WT and Mut cells responsive. These cells express 
endogenous TLR9; overexpression of TLR9HA does not rescue CpG 
responsiveness of Mut cells (Supplementary Fig. S1). Taken together, 
we conclude that TLR3 folding is independent of gp96. Thus, gp96 
KO cells phenocopy the TLR defects of CNPY3 KO cells25.
gp96 forms a complex with CNPY3 in multiple cell types. Given 
the remarkable similarities of TLR phenotypes between gp96 and 
CNPY3 KO mice10,25, we suspected that CNPY3 might be a cochap-
erone of gp96 for TLR folding. If so, gp96 should bind to CNPY3. 
We addressed this prediction in multiple cell types. We found that 
gp96 and CNPY3 colocalize with each other intracellularly (Fig. 2a). 
Both proteins are localized in the ER as identified by an ER marker 
calnexin (CNX) but not with a lysosomal marker lysosomal-asso-
ciated membrane protein-2 (Supplementary Fig. S2). More impor-
tant, gp96 coimmunoprecipitates with the endogenous CNPY3 in 
Raw264.7 macrophages and primary bone marrow-derived macro-
phages (Fig. 2b). We also observed that gp96 forms a complex with 
the C-terminal FLAG-tagged CNPY3 (CNPY3-FLAG) in HEK293 
cells  (Fig.  2c)  and  pre-B  cells  (Fig.  2d).  By  generating  deletion 
mutants of gp96, we further showed that the first 355 amino acids of 
the N domain and part of the M domain of gp96 (N355) were suf-
ficient to interact with CNPY3 (Fig. 2e). The C-terminal domain of 
gp96 (C150) does not interact with CNPY3 (Fig. 2e).
If  gp96–CNPY3  interaction  is  functionally  required  for  TLR 
folding, two predictions can be made. First, TLR must interact with 
gp96–CNPY3 to form a trimolecular complex during the folding 
process.  Second,  abrogation  of  gp96–CNPY3  interaction  should 
lead to defective TLR folding. Using TLR9 as a substrate, we found 
that both of these two predictions were correct. We expressed a   
C-terminal haemagglutinin (HA) epitope-tagged TLR9 in pre-B cells 
that coexpress gp96 and CNPY3-FLAG. We subjected the cells to   
treatment with a thiocleavable crosslinker, dithiobis succinimidyl 
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propionate,  to  maintain  tertiary  stable  complexes  before  immu-
noprecipitation for TLR9HA. The immunoprecipitates were then 
eluted with HA peptide, followed by either reimmunoprecipitation 
for CNPY3 or gel filtration analysis. The final product was identi-
fied by immunoblot for TLR9, CNPY3 and gp96. The sequential 
immunoprecipitation  analysis  indeed  demonstrated  that  TLR9 
forms a molecular complex with both CNPY3 and gp96 (Fig. 2f), 
which was confirmed by coelution of all three proteins from the 
gel filtration column (Fig. 2g). Consistent with no roles of gp96 
or CNPY3 in TLR3 folding, similar analysis failed to demonstrate 
any interaction between TLR3 and gp96/CNPY3 (Fig. 2g). We next 
performed mutagenesis to determine the influence of loss of gp96–
CNPY3 interaction on their ability to fold TLR9. We found that a 
single point mutation of gp96 at amino acid 103 (Glu) (gp96E103A) 
knocked down its ability to interact with CNPY3 (Fig. 2h), which 
correlated with the loss of chaperone function for TLRs but not for 
integrins (Fig. 2i). Similarly, we found that the loss-of-function vari-
ant CNPY3M145K (ref. 31) was unable to interact with gp96 (Fig. 2j). 
Taken together, we concluded that gp96–CNPY3 interaction is criti-
cal for folding TLR9.
CNPY3 binds to gp96 directly. To determine whether gp96 directly 
interacts  with  CNPY3,  we  performed  an  in  vitro  binding  assay 
between purified mouse gp96 and recombinant C-terminal GST 
(glutathione-S-transferase)-tagged CNPY3 (CNPY3-GST) (Fig. 3a). 
We found that gp96 was able to directly interact with both soluble 
(Fig. 3b) and immobilized CNPY3-GST but not with control protein 
GST (Fig. 3c). As HSP90 cochaperones are known to modulate the 
ATP-binding properties of HSP90, we examined the effect of ATP 
on CNPY3–gp96 interaction. We found that ATP dose-dependently 
inhibited the binding of gp96 to CNPY3 (Fig. 3d). ATP hydrolysis 
was not critical for such an inhibition, as the association between 
gp96 and CNPY3 could be prevented by a non-hydrolysable ATP 
analogue AMP-PNP (Fig. 3d), as well as by ADP (Fig. 3e). CNPY3 
has neither intrinsic ATPase activity nor the ability to significantly 
modulate the ATPase activity of gp96 (Supplementary Fig. S3). These 
data,  in  conjunction  with  the  fact  that  the  ATP-binding  mutant 
gp96E103A was unable to interact with CNPY3, suggest that CNPY3 
binds to the adenosine nucleotide-sensitive N domain of gp96.
CNPY3  is  required  for  gp96  to  chaperone  TLR9.  We  next 
addressed the roles of CNPY3 in the ability of gp96 to chaper-
one TLR9. We knocked down CNPY3 using a short hairpin RNA 
(shRNA) lentiviral vector. This strategy effectively silenced CNPY3, 
as evidenced by significant reduction of CNPY3 mRNA (Fig. 4a), 
cell surface TLR4 expression (Fig. 4b), as well as functional loss of 
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Figure 1 | gp96 is dispensable for TLR3 function. (a) Peritoneal mφ from tlr3 − / − , tlr2 − / − tlr4 − / − , hsp90b1 knockout (Ko) and control mice were stimulated 
with polyI:C (100 µg ml − 1), lipopolysaccharide (LPs) (1 µg ml − 1) or medium (none) in the presence of brefeldin A (BFA) for 6 h. Cells were then stained and 
analysed for intracellular cytokine by flow cytometry. numbers represent the percentage of cells in each quadrant over the total number of cells analysed. 
(b) Purified CD19 +  splenic-B cells from various mice were stimulated with polyI:C (100 µg ml − 1), LPs (1 µg ml − 1) or phorbol 12-myristate-13-acetate and 
ionomycin (P/I) for 6 h. Cells were then analysed for surface CD69 by flow cytometry. open histograms represent CD69 stain and shaded histograms are 
isotype controls. (c) puno-TLR3HA or puno-TLR9HA expression vectors were introduced into WT and gp96 mutant pre-B cells. Cells were stimulated 
with polyI:C (100 µg ml − 1) or LPs (1 µg ml − 1) for 12 h, before flow cytometric analysis for nuclear factor-κB-driven green fluorescent protein (GFP). numbers 
represent % of GFP +  cells. Three experiments were conducted with similar results.ARTICLE
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multiple TLRs including TLR2, TLR4, TLR7 and TLR9 (Fig. 4c,d). 
Moreover,  consistent  with  the  idea  that  only  fully  folded  TLR9 
proceeds from the ER to the endolysosome for further proteolytic 
cleavage  in  this  compartment17,18,  CNPY3  silencing  resulted  in 
loss of the mature, cleaved form of TLR9 (TLR9 m, ~80 kDa, Fig. 
4e). The expression level and stability of gp96 or full-length TLR9 
were unaffected by CNPY3 interference (Fig. 4e,f), suggesting that 
CNPY3 is not the chaperone of gp96 per se. We next performed 
coimmunoprecipitation  analysis  to  determine  whether  CNPY3 
reduction affects the interaction between gp96 and TLR9. We were 
able to pull down similar levels of gp96 from control and CNPY3 
shRNA-treated cells with gp96 antibody. However, gp96-associated 
TLR9 was significantly reduced in the absence of CNPY3 (Fig. 4f). 
Similar results were obtained using a small interfering RNA oligo 
(siRNA) that targets a different region of CNPY3 (Fig. 4f). We thus 
concluded that CNPY3 facilitates gp96 to chaperone TLR9, perhaps 
by locking ATP-free gp96 in a relaxed state for TLR9 loading.
The chaperone function of CNPY3 is dependent on gp96. To 
gauge the roles of gp96 in CNPY3 function, we attenuated gp96 
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(Fig. 5e). Taken together, our data demonstrated that gp96 and 
CNPY3 are dependent on each other for TLR9 binding, which 
is consistent with a model that CNPY3 facilitates TLR9 loading   
to free gp96.
gp96 and CNPY3 chaperone the ectodomain of multiple TLRs. 
TLR molecules are sorted to different subcellular compartments 
through localization signals in the tm region and cytosolic tail of 
TLRs32–34. As both CNPY3 and gp96 reside in the ER lumen, we 
hypothesized that gp96 and CNPY3 assist the folding of ectodomains 
of TLRs, except that of TLR3. To directly address this hypothesis, 
we generated a TLR fusion protein that contains the ectodomain 
of TLRs and the tm domain of the platelet-derived growth factor 
receptor (Fig. 6a)35,36. The tm domain and the entire cytoplasmic tail 
of TLRs were deleted to avoid the potential impact of cytoplasmic 
signalling tails on cell surface expression of TLR fusion proteins. 
We reasoned that surface expression of these fusion TLRs is a good 
indication of their folding status, as misfolded proteins would not 
be allowed to exit ER because of the well-known ER protein quality 
control mechanism37.
expression  in  macrophages  by  gp96  shRNA.  We  found  that 
CNPY3 expression is not compromised by the reduction of gp96 
(Fig. 5a). Similar to the defect of TLR9 cleavage in single CNPY3 
knockdown cells, we found that TLR9 cleavage failed to occur in 
the absence of gp96 (Fig. 5b). Furthermore, on the basis of the 
differential sensitivity to endoglycosidase Endo H and PNGase F, 
and the fact that TLR9 cleavage occurs in the endolysosome, we 
found that TLR9 precursors were trapped in the ER of cells with 
silenced expression of either gp96 or CNPY3 (Fig. 5b). We next 
examined the roles of gp96 in CNPY3–TLR9 interaction in WT 
and gp96 KO pre-B cells. We found no difference in the expression 
of CNPY3 or TLR9 between these two cell types (Fig. 5c). How-
ever, the cooperative roles of gp96 and CNPY3 in TLR9 folding 
suggest that CNPY3 alone is unable to efficiently chaperone TLR9. 
To address this hypothesis, we compared the level of the CNPY3–
TLR9 complex in gp96 WT and KO B cells. We found that both 
TLR9 and gp96 could be pulled down, along with CNPY3, in WT 
cells, but the amount of TLR9 that was coprecipitated with CNPY3 
was significantly reduced in gp96 KO cells (Fig. 5d). Similarly, very 
little CNPY3 was coprecipitated with TLR9 in the absence of gp96 
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Figure 3 | gp96 directly interacts with CNPY3. (a) Characterization of 
gp96, recombinant GsT and CnPY3-GsT by immunoblot and coomassie 
blue staining after resolution on 10% sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (sDs–PAGE). (b) GsT or CnPY3-GsT 
was preincubated with glutathione beads, followed sequentially by blocking 
with bovine serum albumin (BsA) and incubation with gp96 for 2 h. The 
pulldown materials were immunoblotted for gp96 or GsT as indicated. 
(c) Plate-bound GsT or CnPT3-GsT was incubated with gp96, followed 
by washing, blocking with BsA and detection of bound gp96 with ELIsA 
in duplicates. Data are means of five independent experiments, error bars 
indicate standard error of mean. *P<0.05. (d) and (e) Effect of adenosine 
nucleotide on gp96-CnPY3 interaction. same as in (c), except that 
various inhibitors at the titrated dose (d) or 1 mm (e) were present during 
incubation with gp96 (10 µg ml − 1). Data points are means of three individual 
experiments. Assays were performed in duplicates. Error bars indicate 
standard error of mean. *P < 0.05.
Figure 4 | CNPY3 promotes gp96–TLR9 interaction. (a) CnPY3 mRnA 
level (mean of duplicates) by a quantitative-PCR (Q-PCR) analysis 
after CnPY3 short-hairpin RnA (shRnA) interference. (b) surface 
TLR4 expression (open histogram) on Raw264.7 cells after shRnA 
knockdown of CnPY3. shaded histograms represent staining with isotype 
control antibody. (c) CnPY3 or control shRnA lentivirus-transduced 
Raw264.7 cells were stimulated with various TLR ligands for 3 h (Pam3 
100 ng ml − 1; lipopolysaccharide 200 ng ml − 1, R848 50 ng ml − 1), followed by 
measurement of tumour-necrosis factor-α in the supernatant by ELIsA. All 
assays were performed in duplicates. Data are means of three independent 
experiments, error bar indicates standard error of mean. *P < 0.05. (d) 
same as (c), except that cells were stimulated with CpG (1 µm) for indicated 
times. Data points are means of three independent experiments. (e) Total 
cell lysates were incubated at 37°C for indicated time and blotted for 
TLR9HA and gp96 in cells transduced with CnPY3 (s) or control (C) shRnA 
lentiviral vector. (f) gp96 IP was performed using cells in (e) (top panel), 
or cells pretreated with CnPY3 siRnA (bottom panel), followed by IB for 
TLR9HA and gp96. Protein expression in whole-cell lysate is also shown.
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As  expected,  there  was  no  cell  surface  expression  of  either 
TLR9HA or TLR3HA in WT or Mut cells (Fig. 6c). Interestingly, 
TLRtms  (TLR3tm,  TLR4tm,  TLR9tm  and  TLR11tm)  can  be 
expressed on the cell surface of WT cells, indicating correct folding 
of these TLRs (Fig. 6b,c). However, with the exception of TLR3tm, 
none of the other TLRtms could be expressed on the surface of cells 
that were devoid of either gp96 (Fig. 6c) or CNPY3 (Fig. 6d). More-
over, we found that gp96 interacted with all other TLRtms, except 
TLR3tm,  by  coimmunoprecipitation  experiment  (Supplementary 
Fig. S4). The cell surface display assay once again reinforced the 
notion that gp96 and CNPY3 have shared function in facilitating 
TLR folding.
To further address the roles of CNPY3 in TLR folding, we over-
expressed TLR9tm or TLR3tm in HEK293 cells that have a low 
level of endogenous CNPY3 (Fig. 7a), followed by immunopre-
cipitation of the respective TLRs and their associated molecules. 
We observed multiple proteins that were coimmunoprecipitated 
with TLR9tm, but not TLR3tm (Supplementary Fig. S5). These 
TLR9tm-associated  proteins  were  identified  by  in-gel  trypsin 
digestion and mass spectrometry, which include gp96, as well as 
multiple other proteins in the ER for protein folding (Fig. 7b). 
Strikingly, when CNPY3 is a limiting factor, there is a clear induc-
tion  of  molecular  chaperones  by  TLR9tm  but  not  by  TLR3tm   
(Fig. 7c). Cotransfection of CNPY3 with TLR9tm led to the atten-
uation of HSP induction (Fig. 7d). We conclude that both gp96 
and CNPY3 must be present to complete the folding cycle of TLR9 
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Figure 5 | CNPY3–TLR9 interaction is dependent on gp96. (a) Expression 
of endogenous CnPY3 and gp96 by Raw264.7 after transduction with 
empty vector (EV), and one or two rounds of gp96 shRnA lentivector. 
β-Actin is shown as a loading control. (b) Lack of cleaved form of TLR9 
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to avoid the overloading and induction of the general molecular 
chaperone machinery in the ER.
Discussion
There are several well-characterized molecules that serve specifi-
cally as HSP90 cochaperones, including HOP, p23, AHA1, CDC37, 
FKBP-52 and UNC45, to facilitate client protein folding9,38. In con-
trast, gp96 cochaperones have not been discovered, leading to a 
long-held notion in the field that this chaperone has a unique and 
cochaperone-independent mode of mechanism of action. This is 
perplexing, given the structural evidence that ATP binding alone is 
not enough to induce a favourable change of the gp96 conformation 
to facilitate client protein folding5,39. Although the post-translational 
regulation of TLRs by both gp96 and CNPY3 has been revealed 
previously, no study has linked the function of these two proteins 
together. In this study, we have demonstrated for the first time that 
CNPY3 is a TLR-specific cochaperone of gp96, on the basis of bio-
chemical, genetic and functional evidence. Specifically, we show the 
following: (i) deletion of either gp96 or CNPY3 results in indistin-
guishable post-translational inactivation of multiple TLRs, except 
TLR3; (ii) gp96 and CNPY3 colocalize in the ER compartment; 
(iii) gp96 and CNPY3 directly interact with each other, and that 
interaction is sensitive to adenosine nucleotide; (iv) the interaction 
between gp96 and CNPY3 was demonstrated in multiple cell types. 
Moreover, gp96 and CNPY3 are present in the same high-molec-
ular-weight complex with TLR9; (v) disruption of the interaction 
between gp96 and CNPY3 by a point mutation of either the gp96 N 
domain (E103A) or CNPY3 (M145K) results in loss of TLR9 func-
tion; (vi) gp96–TLR9 interaction is dependent on the presence of 
CNPY3; (vii) CNPY3 does not interact efficiently with TLR9 in the 
absence of gp96; (viii) TLR9 cleavage and maturation did not occur 
in the absence of either gp96 or CNPY3 and; (ix) in the absence of 
CNPY3, overexpression of the TLR9 ectodomain strongly induces 
protein chaperones in the ER. Our conclusion explains the com-
plete phenocopy of TLR defects in gp96 KO-10 and CNPY3-null 
mice25,28, and it is consistent with the fact that these two molecules 
are colocalized in the ER lumen, coexpressed in multiple cell types 
and codistributed phylogenetically. The requirement for cochaper-
ones in folding client proteins by gp96 is unexpected and novel, and 
our study thus represents a significant advancement in the field of 
HSP90 biology.
By sequential immunoprecipitation and gel filtration, we have 
demonstrated that TLR9 is present in the high-molecular-weight 
complex that contains both gp96 and CNPY3. The ternary com-
plex was also confirmed by coimmunoprecipitation from all three 
directions. However, the stoichiometry of this interaction remains 
unclear. Both TLR9 and gp96 are known to form dimers. CNPY3 
may also homodimerize or oligomerize. Thus, the TLR, gp96 and 
CNPY complex could be at 2:2:2 ratio, making the size of the com-
plex reach at least ~600 kDa, which is consistent with our gel filtra-
tion data. The precise roles of CNPY3 in assisting the gp96-depend-
ent step of TLR folding also require further experimentation. It is, 
however, revealing to consider our data in the context of the known 
gp96 structure. The function of gp96 in folding TLRs is dependent 
on both ATP binding and ATPase activity11,40. The structure of the 
near full-length gp96 dimer in complex with AMP-PNP and ADP 
revealed an identical twisted ‘V’-shape conformation with closed C 
domains and open N domains in opposing orientation5. This confor-
mation most likely reflects a relaxed low-energy state of gp96. Thus, 
ATP binding of gp96 does not drive it into a hydrolytically produc-
tive conformation because of the open N domain and relaxed N–M 
orientation, which leaves the critical residue R448 for the ATPase 
activity of gp96 too distant from the γ phosphate of the ATP. The 
structural study of gp96 thus argues strongly for additional acces-
sory molecules for gp96 to complete its chaperone cycle. We found 
that CNPY3 binds to the N domain of gp96 (N355) and this binding 
is lost with a single E103A mutation or in the presence of ATP. These 
data support the contention that CNPY3 binds to the region in the 
N domain close to the ATP-binding pocket of gp96. Similar to the 
action of cdc37 for HSP90 (refs. 41,42), by binding to the ATP-free 
N domain of gp96, CNPY3 likely keeps gp96 in the relaxed state to 
allow ‘loading’ of substrates onto the free gp96. Although specula-
tive, this idea is consistent with our observation that CNPY3–gp96 
interaction is critical for their binding to TLR9. The binding of 
substrates likely then induces further conformational changes of 
the gp96 N domain, resulting in an ATPase-dependent folding of 
bound substrates.
Our work, however, does not exclude the functions of CNPY3 by 
itself in folding other gp96-independent protein substrates. Equally 
important, CNPY3 is not required for gp96 in folding the entirety of 
the gp96 clientele. For example, gp96 is also a molecular chaperone 
for select integrins, including α4 and β211,12. However, this function 
of gp96 does not depend on CNPY3, as integrin expression is normal 
in CNPY3 KO cells25. In addition, we demonstrated that gp96E103A 
was unable to complex with CNPY3, and thus lost its TLR chaper-
one function. Yet, gp96E103A retains its ability to chaperone integrins. 
Taken together, the cochaperone property of CNPY3 for gp96 is 
  substrate  specific.  There  are  many  precedents  for  client  protein-
  specific cochaperones of HSP90, including CDC37 for the folding of 
kinases42, FKBP-52 for steroid receptors43 and UNC45 for myosin44.
The structural basis by which TLR3 and TLR9 have a dramatic 
difference in their requirement for gp96/CNPY3 remains unclear. 
As TLR3 is heavily glycosylated45, one possibility would be that 
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the glycosylation of TLR3 alone serves as an effective chaperoning 
mechanism, relegating it somewhat independent of additional pro-
tein chaperones. Another possibility that is yet to be ruled out is the 
presence of TLR3-unique chaperone(s) that replaces the function of 
gp96 and CNPY3.
Our data allow us to propose the following model on the coor-
dinated roles of gp96 and CNPY3 in the step-wise folding of TLR9 
(Fig.  8).  We  believe  that  the  initial  folding  and  glycosylation  of 
nascent TLR9 (TLR9 precursor 0) is mediated by the conventional 
glycoprotein folding machinery, including the CNX and calreticulin 
cycle and other ER chaperones such as grp78 and gp96. The role 
of gp96 in the initial folding of nascent TLR9 is not dependent on 
CNPY3, but rather represents a component of the general ER pro-
tein folding machinery6,46,47. Neither gp96 nor CNPY3 alone is able 
to fold TLRs to their full maturation status. As the binding of TLR9 
by CNPY3 and gp96 is dependent on each other, we suggest that 
the CNPY3-gp96 interaction is essential for adopting a favourable 
conformation of both proteins in order to bind and fold TLR9 in the 
ER. Only fully folded TLR9 (TLR9 precursor 2) then translocates to 
the endolysosome with the aid of unc93b16. In the acidic environ-
ment, TLR9 then fully matures into a functional receptor through 
the proteolytic cleavage of the N-terminal 14 LRRs by cathepsins17,18 
or other proteases48.
In conclusion, we have uncovered a sophisticated mechanism of 
TLR folding in the ER that depends on gp96 and its cochaperone 
CNPY3. The mutual dependence of gp96 and CNPY3 is restricted 
to the folding of TLRs but not integrins. Neither gp96 nor CNPY3 
alone is able to chaperone TLRs. Further studies are imperative 
to  understand  the  regulation  of  the  gp96–CNPY3  interaction, 
  including the site, duration and affinity of their interaction, the pre-
cise roles of CNPY3 in regulating other aspects of gp96 function and 
to identify additional cochaperones and mechanisms of gp96 for   
folding non-TLR client proteins.
Methods
Mice and cell lines. hsp90b1flox mice and Mφ-specific gp96 KO mice were 
described previously10. tlr2 − / − tlr4 − / −  mice were generated in-house by intercrossing 
respective single KO mice. tlr3 − / −  mice22 were obtained from A. Vella (University of 
Connecticut). All mice were kept in specific pathogen-free conditions and handled 
in accordance with the National Institutes of Health federal guidelines. gp96-
mutant and WT pre-B cell lines were provided by B. Seed (Harvard University). 
HEK293FT cells were purchased from Invitrogen. Phenoix-Ecotropic retrovirus 
packaging cells were obtained from A. Adler (University of Connecticut).
Constructs. pUNO vectors expressing C-terminal HA-tagged mouse TLR com-
plementary DNAs (pUNO-mTLR-HA), including TLR3, TLR4, TLR9 and TLR11, 
were purchased from Invivogen. To generate TLR9HA retrovector, we amplified 
TLR9HA from pUNO-TLR9HA and inserted it between BglII and EcoRI cloning 
sites on MigR and BLR. The pDisplay vector was purchased from Invitrogen. The 
surface expression of TLRtm was monitored by antibody against the HA epitope 
embedded immediately after the signal peptide in the engineered chimeras. The 
ectodomains of TLR3 (aa 26–705), TLR4 (aa 26–638), TLR9 (26–819) and TLR11 
(22–709) were subcloned into pDisplay and were designated as TLRtm constructs. 
The TLRtm expression cassettes were further subcloned into MigR to generate 
MigR-TLRtm. pLentiCNPY3 shRNA vector was constructed using the pLL3.7 
vector, targeting the 5′-GAGTTTGAAGAGGTGATTGAG-3′ sequence of murine 
CNPY3 and propagated using 293 FT cells (ATCC). The GST-tagged complete 
coding sequence of murine CNPY3 complementary DNA was PCR amplified and 
cloned into pGEX plasmid (GE Healthcare).
Quantitative-polymerase chain reaction. Total RNA was extracted with the 
NucleoSpin RNA II kit according to the manufacturer’s protocol (Clontech). The 
mRNA was reverse transcribed with Superscript II (Invitrogen). Complementary 
DNA was quantified by quantitative-polymerase chain reaction (Q-PCR) with  
Bio-Rad iCycler. Q-PCR data were analysed with the corresponding software, and 
the number of PCR cycles to reach the threshold of detection (Ct) was calculated. 
Samples were run in duplicates. β-Actin was used as an internal control. The primer 
sequences of CNPY3 are as follows: forward, 5′-AAAGGACACGAGTTGCCTAG 
CAGA-3′; reverse, 5′-TCTGCTAGGCAACTCGTGTCCTTT-3′.
Antibodies and enzyme-linked immunosorbent assay. Lipopolysaccharide 
(from Escherichia coli, serotype O55:B5), brefeldin A, phorbol 12-myristate- 
13-acetate, radicicol and ionomycin were purchased from Sigma-Aldrich. polyI:
C, R848, CpG and GpC were obtained from Invivogen. CNPY3 stealth small 
interfering RNA oligos (5′-CCCGCUGCCUCUUAUUUCCUUUGCU-3′) and 
control oligo (5′-CCUGCCUCUUAUUUCCUUUGCGCU-3′) were obtained 
from Invitrogen. Glutathione sepharose 4B was purchased from GE Healthcare. 
  Glutathione was obtained from Sigma-Aldrich. The antibodies used in this study 
were reactive to gp96 (9G10) and grp78 (Stressgen), gp96 (Everest), CNX (Santa 
Cruz Biotechnology), FLAG epitope and β-actin (AC-74) (Sigma-Aldrich), HA 
(16B12) (Covance), GST (GenScript), IL-6, tumour-necrosis factor-α, TLR2 and 
CD69 (eBiosciences) and CNPY3 (Sigma-Aldrich). Cytokine levels were measured 
using ELISA kits from BD Biosciences according to the manufacturer’s protocol.
Protein purification and in vitro binding and ATPase assay. gp96 was purified 
from mouse livers using an established method3, which consists of cell fractiona-
tion, ultracentrifugation, Con A-Sepharose and DEAE chromatography. GST 
and GST-tagged mouse CNPY3-GST were expressed in E. coli and purified by 
glutathione-affinity chromatography. DnaK was removed by ADP-agarose column 
(Sigma-Aldrich). An enzyme-linked immunosorbent assay (ELISA)-based method 
was used to determine whether CNPY3 directly interacts with gp96. In brief, a 
96-well ELISA plate was coated with CNPY3-GST or GST overnight, followed by 
blocking with 3% bovine serum albumin, and washing and incubation with differ-
ent concentrations of gp96 in the presence or absence of ATP, ADP, AMP-PNP and 
radicicol at room temperature for 2 h. The plate was then washed and incubated 
with a rabbit gp96 antibody, followed by treatment with an HRP-conjugated 
secondary antibody. After a thorough wash, the plate was developed with tetram-
ethylbenzidine substrate solution and the optical density was read at 450 nm. The 
ATPase activity of gp96 with and without CNPY3 was performed using γ-p32-ATP 
as described49.
Flow cytometry. Surface staining of cells and flow cytometry were carried out as 
described10,36. To stain intracellular cytokines, cells were fixed in 4% paraformalde-
hyde and permeabilized in 0.25% saponin. Cells were acquired on FACS Calibur 
(Becton Dickinson) and results were analysed with FlowJo software (Tree Star).
Immunoblot. Cells were washed twice in cold phosphate-buffered saline (PBS), 
pelleted and lysed in RIPA buffer (1% NP40, 1% sodium deoxychloate, 0.1% 
sodium dodecyl sulphate (SDS), 150 mM NaCl, 2 mM EDTA, 0.01 M sodium phos-
phate pH 7.2 supplemented with protease inhibitor cocktail). Protein concentration 
of the postnuclear lysate was quantified by Bradford assay (BioRad). Samples were 
denatured by mixing with SDS loading buffer and dithiothreitol, heated at 95 °C for 
5 min and spun to remove pellets. Samples were run on 10% SDS–polyacrylamide 
gel electrophoresis, and transferred onto polyvinylidene difluoride membrane 
after electrophoresis. The membrane was blocked with 5% milk/PBS, followed by 
sequential incubation with primary antibody and horseradish peroxidase-con-
jugated secondary antibody. After extensive washing, the membrane was soaked 
in substrate solution (Pierce) for 5 min. Luminescent signals were recorded on 
X-Omat LS film.
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Figure 8 | A model for the coordinated roles of ER chaperones in 
TLR9 folding. The initial folding and glycosylation of nascent TLR9p0 
(TLR9 precursor 0) are mediated by the ER general glycoprotein-folding 
machinery, including calnexin (CnX) and calreticulin (CRT). CnPY3 and 
gp96 must form a complex to more efficiently interact with TLR9p1 (TLR9 
precursor 1). gp96–CnPY3 accelerates the tertiary folding of TLR9. Folded 
TLR9p2 (TLR9 precursor 2) then dissociates from the gp96–CnPY3 
complex and translocates to the endolysosome with the aid of the 
membrane protein unc93b. TLR9 completes its maturation cycle after 
proteolytic cleavage of the first n-terminal 14 LRRs in the endolysosome. 
Dotted line represents steps that are not fully characterized.ARTICLE     
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Immunoprecipitation and gel filtration. Unless otherwise indicated, cells were 
treated with 0.5 mM dithiobis succinimidyl propionate for 30 min, followed by 
lysis in RIPA buffer. An equal amount of lysate was precleared with protein G 
beads for 4 h. Precleared lysates were further incubated with anti-HA monoclonal 
antibody/protein G beads at 4 °C overnight. The antibody–bead complexes were 
then extensively washed with RIPA buffer. The bound proteins were eluted by heat-
ing the beads at 95 °C in reducing SDS-loading buffer. For mass-spectrum analysis, 
sequential immunoprecipitation and gel filtration, the bound proteins were eluted 
by incubating with HA peptide (Sigma-Aldrich) at 37 °C for 15 min. For gel filtra-
tion, the complex was resolved on a Superdex-200 10/300 GL column (GE Health-
care) at a flow rate of 0.5 ml min − 1 and fractions were collected on a volume base 
(0.5 ml per tube) throughout the chromatogram. Each fraction was concentrated 
and visualized by SDS–polyacrylamide gel electrophoresis, followed by immuno-
blotting. The column was calibrated by performing an identical chromatographic 
separation with a mixture of molecular mass standards (Bio-Rad).
Transfection. To express epitope-tagged TLRs ectopically in HEK293 cells, cells 
were transfected with TLRtm or CNPY3 expression vector using lipofectamine 
2000 (Invitrogen) according to the manufacturer’s protocol. WT and gp96 mutant 
pre-B cells11 were transiently transfected with pUNO-TLR-HA by nucleotransfec-
tion (Amaxa).
Retroviral transduction. Cells were seeded in a 24-well plate and cultured in fresh 
complete growth medium. One day later, cells were spin-infected with recombinant 
retrovirus (1000 g, 32 °C, 90 min) in a desktop centrifuge.
In-gel digestion and LC-MS/MS analysis. This was performed as previously 
described without significant modifications50. Trypsin-digested proteins were ana-
lysed using a linear ion trap mass spectrometer (Finnigan LTQ, Thermo Finnigan). 
  Samples were loaded onto a 10-cm×100-µm capillary C18 reverse-phase column by 
a microautosampler (Famos, Dionex), followed by LC-MS/MS (liquid chromato-
graphy-mass spectrometry-tandem mass spectrometry) analysis on the LTQ. The 
mass spectrometry data file was searched against the current human protein database.
Immunofluorescence microscopy. CNPY3-FLAG-transduced Raw264.7 cells 
were seeded and cultured on glass coverslips at 37 °C overnight, washed with 1× 
PBS, fixed immediately with 4% paraformaldehyde, permeablized with 100% cold 
methanol and blocked for 60 min in 5% normal goat serum. Cells were stained  
sequentially with gp96 antibody, Alexa Fluor-488 goat antirat antibody (gp96, 
green), mouse anti-FLAG antibody and Alexa Fluor-594 (CNPY3, red). Nuclei 
were counterstained with 4,6-diamidino-2-phenylindole. Isotype control antibody 
was also used to ensure specificity (data not shown). Samples were mounted onto 
glass slides with a mounting medium (Biomedia) to retard photobleaching, sealed 
with nail enamel and imaged with a Zeiss LSM 510 Axiovert 100 confocal micro-
scope equipped with an argon/krypton laser (Zeiss).
Statistical analysis. Student’s t-test was used for statistical analysis. Values of 
P < 0.05 were considered to represent statistically significant differences. 
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